Synthesis of methotrexate-conjugated gold nanoparticles with enhanced cancer therapeutic effect
Authors:
- Ngoc Thi Thanh TranNTNgoc Thi Thanh Tran
- Tzu-Hao WangTWTzu-Hao Wang
- Chiao-Yun LinCLChiao-Yun Lin
- Yian TaiYTYian Tai
- 1 September 2013
- journal article
- Published by Elsevier in Biochemical Engineering Journal
- Vol. 78, 175-180
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- A strategy for ZnO nanorod mediated multi-mode cancer treatmentBiomaterials, 2011
- Drug Targeting Strategies in Cancer Treatment: An OverviewMini-Reviews in Medicinal Chemistry, 2011
- Outcome of treatment of adult acute lymphoblastic leukemia with hyperfractionated cyclophosphamide, doxorubicin, vincristine, dexamethasone/methotrexate, cytarabine: results from an Australian populationLeukemia & Lymphoma, 2010
- Targeting RSK2 in human malignanciesExpert Opinion on Therapeutic Targets, 2010
- Optimal treatment for recurrent/metastatic head and neck cancerAnnals of Oncology, 2010
- Anti‐breast cancer potential of SS5020, a novel benzopyran antiestrogenInternational Journal of Cancer, 2010
- The Cancer Preventive Seed Peptide Lunasin From Rye Is Bioavailable and BioactiveNutrition and Cancer, 2009
- Cancer Surpasses Heart Disease as Leading Cause of Death for All But the Very ElderlyJNCI: Journal of the National Cancer Institute, 2005
- Controlled release of anticancer drug methotrexate from biodegradable gelatin microspheresJournal of Microencapsulation, 1994
- Formulation and Characterization of Magnetic Polyglutaraldehyde Nanoparticles as Carriers for Poly-l-Lysine-MethotrexateDrug Development and Industrial Pharmacy, 1990